{
    "SPADE_UN_18885": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18885",
            "Peptide Name": "SE-33-A2P (hybrid peptide, synthetic AMPs, UCll1)",
            "Source": "hybrid peptide hybrid peptide, designed",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "SETRPVLNRLFRLFDKIRQVIRQVIRKFEKGIKEKSKRFFEGRGSLLTCGDVEENPGP",
            "Sequence Length": 58,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 6819.85,
            "PI": 10.27,
            "Hydrophobicity": -0.72,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Gasanov V, Vorotelyak E, Vasiliev A. 2024",
                    "Reference": "Antibiotics (Basel). 2024 Feb 16;13(2):190. doi: 10.3390/antibiotics13020190.PubMed",
                    "Title": "Expression of the Antimicrobial Peptide SE-33-A2P, a Modified Analog of Cathelicidin, and an Analysis of Its Properties."
                }
            ],
            "Frequent Amino Acids": "REK",
            "Absent Amino Acids": "AHMOUWY",
            "Basic Residues": 14,
            "Acidic Residues": 8,
            "Hydrophobic Residues": 21,
            "Polar Residues": 28,
            "Positive Residues": 14,
            "Negative Residues": 8,
            "Net Charge": 6,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (56.9%) toSE-33The A2P peptide (EGRGSLLTCGDVEENPGP), a self-cleaving peptide, is attached to the end of SE-33 peptide for multiple-copy expression. This expression is toxic to E. coli.Activity: active against E. coli (MIC 35-45 ug/ml), S. aureus (MIC 35 ug/ml), and L. casei (MIC 30-35 ug/ml).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_18884",
                    "Similarity": 1.0,
                    "Sequence": "SETRPVLNRLFDKIRQVIRKFEKGIKEKSKRFF"
                },
                {
                    "SPADE_ID": "SPADE_UN_18940",
                    "Similarity": 0.9166666666666666,
                    "Sequence": "RLFDKIRQVIRK"
                },
                {
                    "SPADE_ID": "SPADE_UN_01706",
                    "Similarity": 0.8461538461538461,
                    "Sequence": "RLFDKIRQVIRKF"
                }
            ]
        }
    }
}